IDO1 and lung carcinoma: Indoleamine 2,3-dioxygenase 1 (IDO1) inhibition within the range of IDO1-expressing myeloid-derived suppressor cells in a mouse model of lung cancer decreased the size of the population of these cells, increased the immunosuppressive effect and sensitized the tumor to radiation [93].